Atlas Trials

Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies

Clinical trial NCT00908167 · COMPLETED

Trial details

NCT number
NCT00908167
Sponsor
St. Jude Children's Research Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaInfantile Leukemia (Both AML and ALL)Myelodysplastic SyndromeMyelodysplastic/Myeloproliferative NeoplasmsBiphenotypic Leukemia
Start date
2009-09-01
Primary completion
2015-06-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.